168 related articles for article (PubMed ID: 26756615)
21. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
22. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
23. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling.
Matsumoto S; Fujii S; Kikuchi A
J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143
[TBL] [Abstract][Full Text] [Related]
24. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.
Harada T; Matsumoto S; Hirota S; Kimura H; Fujii S; Kasahara Y; Gon H; Yoshida T; Itoh T; Haraguchi N; Mizushima T; Noda T; Eguchi H; Nojima S; Morii E; Fukumoto T; Obika S; Kikuchi A
Mol Cancer Ther; 2019 Mar; 18(3):602-612. PubMed ID: 30647122
[TBL] [Abstract][Full Text] [Related]
25. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
26. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
[TBL] [Abstract][Full Text] [Related]
27. High Rab27A expression indicates favorable prognosis in CRC.
Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.
Miyata Y; Kumagai K; Nagaoka T; Kitaura K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Cancer Biomark; 2015; 15(6):789-97. PubMed ID: 26406403
[TBL] [Abstract][Full Text] [Related]
29. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
30. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.
Xie N; Bai Y; Qiao L; Bai Y; Wu J; Li Y; Jiang M; Xu B; Ni Z; Yuan T; Shi Y; Wu K; Xu F; Wang J; Dong L; Liu N
J Cell Mol Med; 2021 Apr; 25(8):4014-4027. PubMed ID: 33724652
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
32. Tumorigenesis and tumor progression related gene expression profiles in colorectal cancer.
Huang MY; Chen HC; Yang IP; Tsai HL; Wang TN; Juo SH; Wang JY
Cancer Biomark; 2013; 13(4):269-79. PubMed ID: 24240588
[TBL] [Abstract][Full Text] [Related]
33. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
[TBL] [Abstract][Full Text] [Related]
34. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
35. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer.
Bian Z; Feng Y; Xue Y; Hu Y; Wang Q; Zhou L; Liu Z; Zhang J; Yin Y; Gu B; Huang Z
Tumour Biol; 2016 May; 37(5):6619-25. PubMed ID: 26643894
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
38. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of MSK1 is associated with tumor aggressiveness and poor prognosis in colorectal cancer.
Fu X; Fan X; Hu J; Zou H; Chen Z; Liu Q; Ni B; Tan X; Su Q; Wang J; Wang L; Wang J
Dig Liver Dis; 2017 Jun; 49(6):683-691. PubMed ID: 28314603
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
